LENZ Therapeutics, Inc. filed its quarterly report on Form 10-Q with the SEC on November 3, 2026, covering the fiscal quarter ended September 30, 2026.
Expro Ltd filed its Form 10-Q for the quarterly period ended September 30, 2026 with the U.S. Securities and Exchange Commission on November 3, 2026, reporting a net loss for the third quarter and elevated merger and integration expense.
The AES Corporation filed its Form 10-Q for the quarterly period ended September 30, 2026 with the U.S. Securities and Exchange Commission on November 3, 2026, disclosing share count, subsidiary structure changes, and regulatory developments including an authorized annual rate increase for AES Ohio.
Mercury General Corporation filed its Form 10-Q for the quarterly period ended September 30, 2026 with the Securities and Exchange Commission on November 3, 2026, reporting a net loss of $13,685 thousand for the third quarter alongside nine-month net income of $440,237 thousand.
Tarsus Pharmaceuticals, Inc. filed its quarterly report on Form 10-Q for the period ended September 30, 2026, with the SEC on November 3, 2026, disclosing financial and operational details for the third quarter of fiscal 2026.
Corebridge Financial, Inc. filed its quarterly report on Form 10-Q for the period ended September 30, 2026, with the Securities and Exchange Commission on November 3, 2026, disclosing financial statements and related information for the third quarter of 2026.
Mercury General Corporation filed a Form 8-K with the SEC on November 3, 2026, announcing the release of its financial results for the third quarter ended September 30, 2026.
Avery Dennison Corporation filed its Form 10-Q for the quarterly period ended September 30, 2026 with the U.S. Securities and Exchange Commission on November 3, 2026, covering the company's fiscal third quarter financial results.
Corcept Therapeutics Incorporated filed its quarterly report on Form 10-Q for the period ended September 30, 2026, with the SEC on November 3, 2026, reporting third-quarter net product revenue of $340,472 thousand and net income of $126,778 thousand.
Huron Consulting Group Inc. filed its quarterly report on Form 10-Q for the period ended September 30, 2026, disclosing third-quarter and nine-month financial results including revenue growth, net income, and balance sheet changes.